117
Participants
Start Date
August 31, 2015
Primary Completion Date
February 28, 2018
Study Completion Date
March 31, 2018
ropivacaine 0.2%
Perineural ropivacaine 0.2% at 8 mL/h (adductor) or 6 mL/h (popliteal) basal rate infusion and a 4 mL patient-controlled bolus with a 30 minute lockout
University California San Diego, San Diego
University of California, San Diego
OTHER